BOSTON (GenomeWeb News) — Embryonic stem-cell researchers at the Burnham Institute and Johns Hopkins University are using Invitrogen's NCode miRNA array platform in their research, according to a company official.
 
The collaborations add embryonic stem-cell research to the list of potential areas that the nascent technology could target — an arena Invitrogen believes could become a boon to its miRNA business. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.